Free shipping on all orders over $ 500

Stattic

Cat. No. M3032
Stattic Structure
Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 45  USD45 In stock
10mg USD 40  USD40 In stock
25mg USD 72  USD72 In stock
50mg USD 112  USD112 In stock
100mg USD 176  USD176 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Stattic is the first nonpeptidic STAT3 inhibitor, potently inhibits STAT3 activation and nuclear translocation with IC50 of 5.1 μM, highly selectivity over STAT1. Stattic inhibits STAT3 phosphorylation (at Y705 and S727).

Product Citations
Protocol (for reference only)
Cell Experiment
Cell lines Ly3 cells
Preparation method MTS
Concentrations ~2.5 μM
Incubation time 48 h
Animal Experiment
Animal models Ly3 parental NOD/SCID IL2R null xenograft
Formulation
Dosages 3.75 mg/kg every day
Administration i.p.
Chemical Information
Molecular Weight 211.19
Formula C8H5NO4S
CAS Number 19983-44-9
Solubility (25°C) DMSO 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Dipak K Poria, et al. The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression

[2] Sijia Li, et al. Stattic alleviates acute hepatic damage induced by LPS/d-galactosamine in mice

[3] Sevda Jafari, et al. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells

[4] Chang-Hong Li, et al. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways

[5] Jochen Schust, et al. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization

Related STAT Products
STAT3-IN-21, cell-permeable, negative control

STAT3-IN-21, cell-permeable, negative control, a peptide, is a negative control for Stat3 activity detection.

STAT3-IN-24, cell-permeable

STAT3-IN-24, cell-permeable (PpYLKTK-mts) is a STAT3 peptide inhibitor.

5-FAM-GpYLPQTV-NH2

5-FAM-GpYLPQTV-NH2 is a fluorescently labeled peptide and has STAT3 inhibitory activity.

Ac-GpYLPQTV-NH2

Ac-GpYLPQTV-NH2 is a STAT3 inhibitor with an IC50 value of 0.33 μM.

XZH-5

XZH-5 inhibits the phosphorylation of STAT3 and results in the induction of apoptosis and reduction of colony forming ability.

  Catalog
Abmole Inhibitor Catalog




Keywords: Stattic supplier, STAT, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.